- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01416519
Physiotherapy Technique Decreases Respiratory Complications After Cardiac Operation
Incentive Spirometry Decreases Respiratory Complications After Myocardial Revascularization
Study Overview
Status
Conditions
Detailed Description
Coronary artery bypass graft (CABG) can prolong and improve the quality of life of patients with ischemic coronary syndrome but with the advancement of medical intervention to eligible patients for this procedure are those with more comorbidities where conservation and palliative therapies have been tried without success.
Patients undergoing CABG often develop pulmonary complications such as atelectasis, restrictive ventilatory defect, decreased lung compliance, increased shunt and changes in gas exchange leading to probable hypoxemia. In an attempt to reduce the harmful effects and pulmonary complications arising from surgical procedures is instituted extensive physiotherapy program that tracks and monitors such patients from the preoperative to the postoperative immediate transfer to the ward and hospital discharge.
The objective of this study is to assess whether there is a difference between a care protocol with the use of incentive spirometry (Voldyne ®) and another with the application of NIV (non invasive ventilation with single-level pressure) as a form of therapy. The main focus of the study is to determine the incidence of pulmonary complications in each technique.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
São Paulo
-
Votuporanga, São Paulo, Brazil, 15500-003
- Santa Casa Votuporanga
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with indication for elective coronary artery bypass surgery who agreed to participate and signed the informed consent.
Exclusion Criteria:
- patients with hemodynamic instability during the physiotherapy care
- those who fail to complete all visits to the proposed protocol (whatever the reason)
- extubation after 12 hours of ICU admission
- major intraoperative hemorrhage
- major bleeding in ICU requiring return to the operating room
- cardiopulmonary arrest
- contraindication to positive pressure (undrained pneumothorax, bronchopleural fistula, hemoptysis, vomiting) or intolerance to the method
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Group 1
After extubation, starting non-invasive ventilation with face mask (1 hour) followed by assisted cough maneuver.
Total of 18 calls in 72 hours distributed as long the patient was extubated.
|
After extubation, starting non-invasive ventilation with face mask (1 hour) followed by assisted cough maneuver.
Total of 18 calls in 72 hours distributed as long the patient was extubated.
Other Names:
|
Experimental: Group 2
After extubation, starting early supplemental oxygen with Venturi (FiO2 50%) with gradual weaning, applying assisted deep inspiration technique with Voldyne(R) with four sets of 10 repetitions and assisted cough maneuver.
Total of 18 calls in 72 hours distributed as long the patient was extubated.
|
After extubation, starting early supplemental oxygen with Venturi (FiO2 50%) with gradual weaning, applying assisted deep inspiration technique with Voldyne(R) with four sets of 10 repetitions and assisted cough maneuver.
Total of 18 calls in 72 hours distributed as long the patient was extubated.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pulmonary complications
Time Frame: 72 hours
|
Occurrence of pulmonary complications such as pneumonia, atelectasis or pleural effusion diagnosed with chest X-rays by ICU doctor.
|
72 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Exams
Time Frame: 72 hours
|
Assessment of (Sat O2) capillary saturation, (ABG) arterial blood gases.
|
72 hours
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Marcos Aurelio Barboza de Oliveira, MD, Santa Casa Votuporanga
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- U1111-1123-6476
- 0035/2010 (Other Identifier: Ethics committee)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pneumonia
-
King Edward Memorial HospitalCompletedNosocomial Pneumonia | Healthcare-Associated Pneumonia | Aspiration Pneumonia | Ventilator-Associated PneumoniaIndia
-
Melinta Therapeutics, Inc.WithdrawnHospital-Acquired Bacterial Pneumonia | Ventilator-Associated Bacterial Pneumonia | Hospital-Acquired Pneumonia | Ventilator-Associated Pneumonia
-
Venatorx Pharmaceuticals, Inc.Biomedical Advanced Research and Development AuthorityNot yet recruitingHospital-acquired Pneumonia | Ventilator-associated Pneumonia
-
PfizerCompletedVentilator-associated Pneumonia (VAP) | Nosocomial Pneumonia (NP)Bulgaria, France, Italy, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, Spain, Turkey, United Kingdom, Vietnam, Philippines, China, Ukraine, Argentina, Brazil, Hungary, Romania, India, Japan, Taiwan, Latvia, Czechia, Slov... and more
-
Arpida AGTerminatedHospital-Acquired Pneumonia | Ventilator-Associated Pneumonia | Health-Care-Associated Pneumonia
-
Hannover Medical SchoolCharite University, Berlin, Germany; University of LeipzigUnknownCOVID-19 | Bacterial Pneumonia | Viral Pneumonia | Pneumonia Due to Streptococcus Pneumoniae | Pneumonia Due to H. Influenzae | Pneumonia, Organism Unspecified | Pneumonia in Diseases Classified Elsewhere | Pneumonia Due to Other Specified Infectious OrganismsGermany
-
Nantes University HospitalSociété Française d'Anesthésie et de RéanimationCompletedPneumonia | Sepsis | Ventilator-Associated Pneumonia | Hospital Acquired PneumoniaFrance
-
University Medical Centre LjubljanaUniversity of Ljubljana, Faculty of MedicineUnknownCommunity Acquired Pneumonia | Ventilator Associated Pneumonia | Hospital Acquired PneumoniaSlovenia
-
ShionogiCompletedHospital Acquired Pneumonia (HAP) | Healthcare-associated Pneumonia (HCAP) | Ventilator Associated Pneumonia (VAP)Israel, Spain, United States, Belgium, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Japan, Latvia, Philippines, Puerto Rico, Russian Federation, Serbia, Taiwan, Ukraine
-
Avicenna Military HospitalCompletedHospital-acquired Pneumonia | Ventilator Associated Pneumonia | Community-acquired PneumoniaMorocco
Clinical Trials on Continuous Positive Airway Pressure (CPAP) facial mask
-
Glenn GreenUniversity of Michigan; American Academy of Otolaryngology-Head and Neck Surgery...CompletedSleep Apnea, Obstructive | Craniofacial Abnormalities | Pediatric DisorderUnited States
-
University of ChicagoCompletedDiabetes | Sleep ApneaUnited States
-
ASST Fatebenefratelli SaccoCompletedContinuous Positive Airway Pressure [E02.041.625.790.259] | Prostatectomy [E04.950.774.860.625] | Laparoscopy [E01.370.388.250.520] | Pneumoperitoneum [C06.844.670]Italy
-
Indiana UniversityNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Eileen R. ChasensCompletedSleep Apnea, Obstructive | Diabetes Mellitus, Type 2United States
-
Sociedad Española de Neumología y Cirugía TorácicaCompletedObstructive Sleep ApneaSpain
-
St. Olavs HospitalNorwegian University of Science and TechnologyCompletedChronic Disease | Cluster HeadacheNorway
-
McGill UniversityCentre hospitalier de l'Université de Montréal (CHUM); Philips Respironics; Multiple... and other collaboratorsCompletedObstructive Sleep Apnea-hypopnea in Multiple Sclerosis PatientsCanada
-
Chinese Pulmonary Vascular Disease Research GroupCompletedObstructive Sleep Apnea | Coronary Heart DiseaseChina
-
Eileen R. ChasensTerminatedObstructive Sleep Apnea | Type 2 DiabetesUnited States